Dr. Steven Self discussed a mathematical modeling analysis of
the potential impact of Mtb exposure intensity and magnitude on
vaccine efficacy (VE) at the population level. While Mtb infection
is clearly not a surrogate for active TB disease, Dr. Self noted that
it may represent a more valid endpoint for assessing TB vaccine
biological activity than immunogenicity endpoints in the absence
of defined correlates of protection from Mtb infection or TB disease.